Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Taal, MW; Brenner, BM
   Achieving maximal renal protection in nondiabetic chronic renal disease
   AMERICAN JOURNAL OF KIDNEY DISEASES
   
   M.W. Taal e B.M. Brenner, "Achieving maximal renal protection in nondiabetic chronic renal disease", AM J KIDNEY, 38(6), 2001, pp. 1365-1371
2. Lewis, EJ; Hunsicker, LG; Rodby, RA
   A clinical trial in type 2 diabetic nephropathy
   AMERICAN JOURNAL OF KIDNEY DISEASES
   
   E.J. Lewis et al., "A clinical trial in type 2 diabetic nephropathy", AM J KIDNEY, 38(4), 2001, pp. S191-S194
3. Jover, B; Herizi, A; Casellas, D; Mimran, A
   Influence of irbesartan and enalapril on changes of renal function associated with the established phase of L-NAME hypertension
   JOURNAL OF HYPERTENSION
   
   B. Jover et al., "Influence of irbesartan and enalapril on changes of renal function associated with the established phase of L-NAME hypertension", J HYPERTENS, 19(11), 2001, pp. 2039-2046
4. Perez, JCR; Cabrera, JJ; Anabitarte, A; Plaza, ML; Losada, A; Suarez, PG; Afonso, JL
   Effects of carvedilol in rats with induced chronic renal failure
   NEFROLOGIA
   
   J.C.R. Perez et al., "Effects of carvedilol in rats with induced chronic renal failure", NEFROLOGIA, 21(1), 2001, pp. 52-58
5. Schaier, M; Lehrke, I; Schade, K; Morath, C; Shimizu, F; Kawachi, H; Grone, HJ; Ritz, E; Wagner, J
   Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
   KIDNEY INTERNATIONAL
   
   M. Schaier et al., "Isotretinoin alleviates renal damage in rat chronic glomerulonephritis", KIDNEY INT, 60(6), 2001, pp. 2222-2234
6. Amlal, H; Chen, Q; Greeley, T; Pavelic, L; Soleimani, M
   Coordinated down-regulation of NBC-1 and NHE-3 in sodium and bicarbonate loading
   KIDNEY INTERNATIONAL
   
   H. Amlal et al., "Coordinated down-regulation of NBC-1 and NHE-3 in sodium and bicarbonate loading", KIDNEY INT, 60(5), 2001, pp. 1824-1836
7. De Greef, KE; Ysebaert, DK; Dauwe, S; Persy, V; Vercauteren, SR; Mey, D; De Broe, ME
   Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia
   KIDNEY INTERNATIONAL
   
   K.E. De Greef et al., "Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia", KIDNEY INT, 60(4), 2001, pp. 1415-1427
8. Weigert, C; Brodbeck, K; Haring, HU; Gambaro, G; Schleicher, ED
   Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation
   KIDNEY INTERNATIONAL
   
   C. Weigert et al., "Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation", KIDNEY INT, 60(3), 2001, pp. 935-943
9. Ogawa, T; Hayashi, T; Yorioka, N; Kyoizumi, S; Trosko, JE
   Hexamethylene bisacetamide protects peritoneal mesothelial cells from glucose
   KIDNEY INTERNATIONAL
   
   T. Ogawa et al., "Hexamethylene bisacetamide protects peritoneal mesothelial cells from glucose", KIDNEY INT, 60(3), 2001, pp. 996-1008
10. Kurts, C; Klebba, I; Davey, GM; Koch, KM; Miller, JFAP; Heath, WR; Floege, J
    Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration
    KIDNEY INTERNATIONAL
    
    C. Kurts et al., "Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration", KIDNEY INT, 60(2), 2001, pp. 664-671
11. Parving, HH; Hommel, E; Jensen, BR; Hansen, HP
    Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients
    KIDNEY INTERNATIONAL
    
    H.H. Parving et al., "Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients", KIDNEY INT, 60(1), 2001, pp. 228-234
12. Hovind, P; Rossing, P; Tarnow, L; Smidt, UM; Parving, HH
    Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively
    KIDNEY INTERNATIONAL
    
    P. Hovind et al., "Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively", KIDNEY INT, 60(1), 2001, pp. 277-283
13. Miyajima, A; Chen, J; Poppas, DP; Vaughan, ED; Felsen, D
    Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction
    KIDNEY INTERNATIONAL
    
    A. Miyajima et al., "Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction", KIDNEY INT, 59(4), 2001, pp. 1290-1303
14. Phillips, AO
    Diabetic nephropathy - where next?
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    A.O. Phillips, "Diabetic nephropathy - where next?", QJM-MON J A, 93(10), 2000, pp. 643-646
15. Susic, D
    Renal protective potential of antihypertensive drugs
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    D. Susic, "Renal protective potential of antihypertensive drugs", EXPERT OP I, 9(11), 2000, pp. 2593-2600
16. Kumagai, H; Hayashi, K; Kumamaru, H; Saruta, T
    Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: A one-year, prospective, randomized study
    AMERICAN JOURNAL OF HYPERTENSION
    
    H. Kumagai et al., "Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: A one-year, prospective, randomized study", AM J HYPERT, 13(9), 2000, pp. 980-985
17. Jover, B; Demeilliers, B
    Angiotensin II type 1 receptor antagonist versus angiotensin I-converting enzyme inhibitor in experimental renal diseases
    FUNDAMENTAL & CLINICAL PHARMACOLOGY
    
    B. Jover e B. Demeilliers, "Angiotensin II type 1 receptor antagonist versus angiotensin I-converting enzyme inhibitor in experimental renal diseases", FUN CL PHAR, 14(6), 2000, pp. 541-548
18. Eddy, AA; Kim, H; Lopez-Guisa, J; Oda, T; Soloway, PD; McCulloch, L; Liu, E; Wing, D
    Interstitial fibrosis in mice with overload proteinuria: Deficiency of TIMP-1 is not protective
    KIDNEY INTERNATIONAL
    
    A.A. Eddy et al., "Interstitial fibrosis in mice with overload proteinuria: Deficiency of TIMP-1 is not protective", KIDNEY INT, 58(2), 2000, pp. 618-628
19. Taal, MW; Brenner, BM
    Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
    KIDNEY INTERNATIONAL
    
    M.W. Taal e B.M. Brenner, "Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists", KIDNEY INT, 57(5), 2000, pp. 1803-1817
20. Ots, M; Pechter, U; Tamm, A
    Characteristics of progressive renal disease
    CLINICA CHIMICA ACTA
    
    M. Ots et al., "Characteristics of progressive renal disease", CLIN CHIM A, 297(1-2), 2000, pp. 29-41
21. Preston, RA
    Renoprotective effects of antihypertensive drugs
    AMERICAN JOURNAL OF HYPERTENSION
    
    R.A. Preston, "Renoprotective effects of antihypertensive drugs", AM J HYPERT, 12(1), 1999, pp. 19S-32S
22. Power, DA; Duggan, J; Brady, HR
    Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: Ineffective and probably dangerous
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    
    D.A. Power et al., "Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: Ineffective and probably dangerous", CLIN EXP PH, 26, 1999, pp. S23-S28
23. Mann, JFE
    Valsartan and the kidney: Present and future
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    J.F.E. Mann, "Valsartan and the kidney: Present and future", J CARDIO PH, 33, 1999, pp. S37-S40
24. Noda, M; Matsuo, T; Fukuda, R; Ohta, M; Nagano, H; Shibouta, Y; Naka, T; Nishikawa, K; Imura, Y
    Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure
    KIDNEY INTERNATIONAL
    
    M. Noda et al., "Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure", KIDNEY INT, 56(3), 1999, pp. 898-909
25. Jandeleit-Dahm, K; Cao, ZM; Cox, AJ; Kelly, DJ; Gilbert, RE; Cooper, ME
    Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathy
    KIDNEY INTERNATIONAL
    
    K. Jandeleit-Dahm et al., "Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathy", KIDNEY INT, 56, 1999, pp. S31-S36
26. Griffin, KA; Picken, MM; Bakris, GL; Bidani, AK
    Class differences in the effects of calcium channel blockers in the rat remnant kidney model
    KIDNEY INTERNATIONAL
    
    K.A. Griffin et al., "Class differences in the effects of calcium channel blockers in the rat remnant kidney model", KIDNEY INT, 55(5), 1999, pp. 1849-1860
27. Burgess, E
    Conservative treatment to slow deterioration of renal function: Evidence-based recommendations
    KIDNEY INTERNATIONAL
    
    E. Burgess, "Conservative treatment to slow deterioration of renal function: Evidence-based recommendations", KIDNEY INT, 55, 1999, pp. S17-S25
28. Uhlenius, N; Tikkanen, T; Miettinen, A; Holthofer, H; Tornroth, T; Eriksson, A; Fyhrquist, F; Tikkanen, I
    Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis
    NEPHRON
    
    N. Uhlenius et al., "Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis", NEPHRON, 81(2), 1999, pp. 221-229
29. MACLAUGHLIN M; MONSERRAT AJ; MULLER A; MATOSO M; AMORENA C
    ROLE OF KININS IN THE RENOPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTINGENZYME-INHIBITORS IN EXPERIMENTAL CHRONIC-RENAL-FAILURE
    Kidney & blood pressure research
    
    M. Maclaughlin et al., "ROLE OF KININS IN THE RENOPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTINGENZYME-INHIBITORS IN EXPERIMENTAL CHRONIC-RENAL-FAILURE", Kidney & blood pressure research, 21(5), 1998, pp. 329-334
30. SUSIC D; FROHLICH ED
    NEPHROPROTECTIVE EFFECT OF ANTIHYPERTENSIVE DRUGS IN ESSENTIAL-HYPERTENSION
    Journal of hypertension
    
    D. Susic e E.D. Frohlich, "NEPHROPROTECTIVE EFFECT OF ANTIHYPERTENSIVE DRUGS IN ESSENTIAL-HYPERTENSION", Journal of hypertension, 16(5), 1998, pp. 555-567
31. FRANCISCHETTI A; ONO H; FROHLICH ED
    RENOPROTECTIVE EFFECTS OF FELODIPINE AND OR ENALAPRIL IN SPONTANEOUSLY HYPERTENSIVE RATS WITH AND WITHOUT L-NAME/
    Hypertension
    
    A. Francischetti et al., "RENOPROTECTIVE EFFECTS OF FELODIPINE AND OR ENALAPRIL IN SPONTANEOUSLY HYPERTENSIVE RATS WITH AND WITHOUT L-NAME/", Hypertension, 31(3), 1998, pp. 795-801
32. ANDRADE L; CAMPOS SB; SEGURO AC
    HYPERCHOLESTEROLEMIA AGGRAVATES RADIOCONTRAST NEPHROTOXICITY - PROTECTIVE ROLE OF L-ARGININE
    Kidney international
    
    L. Andrade et al., "HYPERCHOLESTEROLEMIA AGGRAVATES RADIOCONTRAST NEPHROTOXICITY - PROTECTIVE ROLE OF L-ARGININE", Kidney international, 53(6), 1998, pp. 1736-1742
33. BREEN D; BIHARI D
    ACUTE-RENAL-FAILURE AS A PART OF MULTIPLE ORGAN FAILURE - THE SLIPPERY SLOPE OF CRITICAL ILLNESS
    Kidney international
    
    D. Breen e D. Bihari, "ACUTE-RENAL-FAILURE AS A PART OF MULTIPLE ORGAN FAILURE - THE SLIPPERY SLOPE OF CRITICAL ILLNESS", Kidney international, 53, 1998, pp. 25-33
34. PARVING HH; ROSSING P; HOMMEL E; SMIDT UM
    ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN DIABETIC NEPHROPATHY - 10YEARS EXPERIENCE
    American journal of kidney diseases
    
    H.H. Parving et al., "ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN DIABETIC NEPHROPATHY - 10YEARS EXPERIENCE", American journal of kidney diseases, 26(1), 1995, pp. 99-107
35. ALBERT FW
    ANTIHYPERTENSIVE DRUGS IN RENAL-FAILURE
    Journal of cardiovascular pharmacology
    
    F.W. Albert, "ANTIHYPERTENSIVE DRUGS IN RENAL-FAILURE", Journal of cardiovascular pharmacology, 24, 1994, pp. 190000108-190000112
36. HARLOS J; GOTZ R; HEIDLAND A
    ANTIHYPERTENSIVE DRUGS AND PROTEINURIA
    Nieren- und Hochdruckkrankheiten
    
    J. Harlos et al., "ANTIHYPERTENSIVE DRUGS AND PROTEINURIA", Nieren- und Hochdruckkrankheiten, 22(11), 1993, pp. 573-582